<SEC-DOCUMENT>0001935979-25-000074.txt : 20250815
<SEC-HEADER>0001935979-25-000074.hdr.sgml : 20250815
<ACCEPTANCE-DATETIME>20250815172245
ACCESSION NUMBER:		0001935979-25-000074
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250815
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250815
DATE AS OF CHANGE:		20250815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Biohaven Ltd.
		CENTRAL INDEX KEY:			0001935979
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41477
		FILM NUMBER:		251225694

	BUSINESS ADDRESS:	
		STREET 1:		215 CHURCH STREET
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
		BUSINESS PHONE:		203-404-0410

	MAIL ADDRESS:	
		STREET 1:		215 CHURCH STREET
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biohaven Research Ltd.
		DATE OF NAME CHANGE:	20220629
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bhvn-20250815.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6555d043-5c7b-4b44-85af-cf97cb86b07f,g:a0978f3d-71d8-409e-8ad4-8e40337b1b3f,d:ba7f032707c94eedbb608f224658ae3d-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bhvn-20250815</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001935979</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bhvn-20250815.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001935979</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-15</xbrli:startDate><xbrli:endDate>2025-08-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iba7f032707c94eedbb608f224658ae3d_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 15, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Biohaven Ltd.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-4">British Virgin Islands</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-41477</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-6">c/o Biohaven Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-7">215 Church Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">New Haven</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Connecticut</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">06510</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">203</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">404-0410</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Not applicable</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric>&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric>&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:37.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Shares, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">BHVN</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iba7f032707c94eedbb608f224658ae3d_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 8.01 Other Events. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On August 15, 2025, Biohaven Ltd. (the &#8220;Company&#8221;) filed a prospectus supplement to its Registration Statement on Form S-3 (No. 333-274822) (the &#8220;Registration Statement&#8221;) filed with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;), under the Securities Act of 1933, as amended, with respect to the resale by the selling shareholder named therein of 3,588,688 common shares, no par value, of the Company that were issued by the Company to such selling shareholder as share consideration in connection with </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">the Amendment to Membership Interest Purchase Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, dated as of May 1, 2024 (the &#8220;Knopp Amendment&#8221;), by and among the Company, Biohaven Therapeutics Ltd., Biohaven Pharmaceuticals, Inc. and the selling shareholder. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the Knopp Amendment, the parties thereto agreed to replace the scaled high single digit to low teens royalty payment obligations under the Membership Interest Purchase Agreement, dated February 24, 2022 (the &#8220;Purchase Agreement&#8221;), among Biohaven Therapeutics LTD., Knopp Biosciences LLC, Channel Biosciences, LLC and Biohaven Pharmaceutical Holding Company Ltd., with a flat royalty payment in the mid-single digits for BHV-7000 and the pipeline programs. The parties also agreed to reduce the success-based payments payable under the Purchase Agreement by removing all commercial sales-based milestones, which were up to $562.5 million, and reducing the developmental and regulatory milestones, which were up to $575 million, to up to $210 million based on regulatory approvals in the United States, Europe, the Middle East and Asia for BHV-7000 ($25 million of which has already been paid) and up to an additional $60 million based on regulatory approval in the United States for the other Kv7 pipeline programs. The Company retains the ability to pay these contingent milestone payments in cash or in its common shares at its election.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the filing of the prospectus supplement, the Company is filing a legal opinion as Exhibit No. 5.1 to this Current Report on Form 8-K, which is incorporated by reference into the Registration Statement. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="iba7f032707c94eedbb608f224658ae3d_10"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">(d) Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:19.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.857%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51maplesopinionandc.htm">Opinion of Maples &amp; Calder.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51maplesopinionandc.htm">Consent of Maples &amp; Calder (included in Exhibit 5.1)</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The cover page of this Current Report on Form 8-K formatted as Inline XBRL.</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2</span></div></div></div><div id="iba7f032707c94eedbb608f224658ae3d_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Date: August 15, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:139%">    </span></div><div style="margin-bottom:1pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.038%"><tr><td style="width:1.0%"/><td style="width:14.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.214%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Biohaven Ltd.</span></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Buten</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Buten</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit51maplesopinionandc.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7c9f28f03a0c430f9b6695b58c394e08_1"></div><div style="min-height:84.96pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Exhibit 5.1</font></div></div><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:142px;margin-bottom:5pt;vertical-align:text-bottom;width:652px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Biohaven Ltd.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Kingston Chambers </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">P.O. Box 173</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Road Town, Tortola</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">British Virgin Islands</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">15 August 2025</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Dear Sirs</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Biohaven Ltd. (the &#34;Company&#34;)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">We have acted as counsel as to British Virgin Islands law to the Company in respect of the proposed resale of an aggregate of 3,588,688 common shares in the Company with no par value (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;) issued on 25 June 2025 to the Selling Shareholder (as defined in the Prospectus Supplement) pursuant to the terms of an amendment to the Membership Interest Purchase Agreement dated as of May 1, 2024 entered into between the Company, Biohaven Therapeutics Ltd, Biohaven Pharmaceuticals, Inc. and Knopp Biosciences LLC (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;). We have been asked to provide this legal opinion in connection with the Company's registration statement on Form S-3, including all amendments or supplements thereto, and the prospectus supplement dated 15 August 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Prospectus Supplement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;) filed with the United States Securities and Exchange Commission (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Commission</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;) under the United States Securities Act of 1933, as amended (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">SEC Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;) (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Registration Statement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;). </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;padding-left:29.89pt">Documents Reviewed</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">We have reviewed originals, copies, drafts or conformed copies of the following documents&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The public records of the Company on file and available for public inspection at the Registry of Corporate Affairs in the British Virgin Islands (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Registry of Corporate Affairs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;) on 14 August 2025, including the Company's Certificate of Incorporation and its Memorandum and Articles of Association (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Memorandum and Articles</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">A list of the Company's directors provided by the Registry of Corporate Affairs dated 13 August 2025 (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Registry List of Directors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:21.43pt">The records of proceedings available from a search of the electronic records maintained on the Judicial Enforcement Management System and the E-Litigation Portal from 1 January 2000 and available for inspection on 14 August 2025 at the British Virgin Islands High Court Registry (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">High Court Registry</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The minutes of the meeting of the board of directors of the Company held on 26-27 February 2024, the written resolutions of the board of directors passed on 16 April 2024 and passed on 15 August 2025 (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Resolutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;). </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">A Certificate of Incumbency dated 14 August 2025, issued by Maples Corporate Services (BVI) Limited, the Company's registered agent (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Registered Agent's Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:84.96pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">A certificate of good standing with respect to the Company issued by the Registrar of Corporate Affairs dated 14 August 2025 (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Certificate of Good Standing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">A certificate from a director of the Company (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Director's Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The Registration Statement.</font></div><div id="i7c9f28f03a0c430f9b6695b58c394e08_4"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;padding-left:29.89pt">Assumptions</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">The following opinions are given only as to, and based on, circumstances and matters of fact existing and known to us on the date of this opinion letter.  These opinions only relate to the laws of the British Virgin Islands which are in force on the date of this opinion letter.  In giving the following opinions we have relied (without further verification) upon the completeness and accuracy, as at the date of this opinion letter, of the Registry List of Directors, the Registered Agent's Certificate, the Certificate of Good Standing and the Director's Certificate.  We have also relied upon the following assumptions, which we have not independently verified&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The Agreement was and is authorised and duly executed and unconditionally delivered by or on behalf of all relevant parties in accordance with all relevant laws (including, without limitation, the laws of the British Virgin Islands). </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The Agreement was and is legal, valid, binding and enforceable against all relevant parties in accordance with its terms under all relevant laws (including, without limitation, the laws of the British Virgin Islands). </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">Copies of documents, conformed copies or drafts of documents provided to us are true and complete copies of, or in the final forms of, the originals.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">All signatures, initials and seals are genuine.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">That all public records of the Company which we have examined are accurate and that the information disclosed by the searches which we conducted against the Company at the Registry of Corporate Affairs and the High Court Registry is true and complete and that such information has not since then been altered and that such searches did not fail to disclose any information which had been delivered for registration but did not appear on the public records at the date of our searches.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The Memorandum and Articles remain in full force and effect and are unamended and that there are a sufficient number of authorised shares to allow for the issuance of the Shares. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The Resolutions were each signed by all the directors in the manner prescribed in the Memorandum and Articles of the Company, including as to the disclosure of any director's interests, and have not been amended, varied or revoked in any respect.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The members of the Company (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Members</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#34;) have not restricted or limited the powers of the directors of the Company in any way.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">No invitation has been or will be made by or on behalf of the Company to the public in the British Virgin Islands to subscribe for any of the Shares.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:15.6pt">The Shares issued pursuant to the Agreement have been, or will be, duly registered, and will continue to be registered, in the Company's register of members.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:15.6pt">The Company has received, or will receive, cash consideration or non-cash consideration in consideration for the issue of the Shares, and that&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;none of the Shares have been, or will be, issued for less than their par value&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:84.96pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;to the extent that any Shares are, or will be, issued, in whole or in part, for non-cash consideration, the value of the non-cash consideration and cash consideration, if any, is not less than the amount credited or to be credited for such Shares.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:15.6pt">The issue of the Shares to the Selling Shareholder by the Company as contemplated by the Agreement, as applicable, was authorised and such Shares were legally issued, fully paid and non-assessable (as a matter of all relevant laws, other than the laws of the British Virgin Islands) and all conditions to the issuance of the Shares pursuant to the Agreement were satisfied.  </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:15.6pt">There is nothing under any law (other than the laws of the British Virgin Islands) which would or might affect the opinions set out below.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Save as aforesaid we have not been instructed to undertake and have not undertaken any further enquiry or due diligence in relation to the transaction the subject of this opinion.</font></div><div id="i7c9f28f03a0c430f9b6695b58c394e08_7"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;padding-left:29.89pt">Opinions</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Based upon, and subject to, the foregoing assumptions and the qualifications set out below, and having regard to such legal considerations as we deem relevant, we are of the opinion that&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">The Shares held by the Selling Shareholder to be resold as contemplated by the Registration Statement were duly authorised, and when issued and paid for in the manner described in the Agreement and in accordance with the Resolutions, such Shares were legally issued, fully paid and non-assessable. As a matter of British Virgin Islands law, a share is only issued when it has been entered in the register of members of the Company.</font></div><div id="i7c9f28f03a0c430f9b6695b58c394e08_10"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;padding-left:29.89pt">Qualifications</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">The opinions expressed above are subject to the following qualifications&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">We have not reviewed the Agreement save as expressly referred to in paragraph 3.1 of this opinion and our opinions are qualified accordingly.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">We express no view as to the commercial terms of the Agreement or whether such terms represent the intentions of the parties and we make no comment with respect to any representations and warranties which may be made by or with respect to the Company in any of the documents or instruments cited in this opinion or otherwise with respect to the commercial terms of the transactions the subject of this opinion.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">4.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">Under British Virgin Islands law, the register of members is </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:100%">prima facie</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%"> evidence of title to shares and this register would not record a third party interest in such shares. However, there are certain limited circumstances where an application may be made to a British Virgin Islands court for a determination on whether the register of members reflects the correct legal position. Further, the British Virgin Islands court has the power to order that the register of members maintained by a company should be rectified where it considers that the register of members does not reflect the correct legal position. For the purposes of the opinion given in paragraph 3.1, there are no circumstances or matters of fact known to us on the date of this opinion letter which would properly form the basis for an application for an order for rectification of the register of members of the Company, but if such an application were made in respect of the Company's Shares, then the validity of such shares may be subject to re-examination by a British Virgin Islands court. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">4.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">Except as specifically stated herein, we make no comment with respect to any representations and warranties which may be made by or with respect to the Company in any of the documents or instruments cited in this opinion or otherwise with respect to the commercial terms of the transactions the subject of this opinion.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">4.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;padding-left:21.43pt">In this opinion letter, the phrase &#34;non-assessable&#34; means, with respect to the issuance of shares, that a shareholder shall not, in respect of the relevant shares and in the absence of a contractual arrangement, or an obligation pursuant to the memorandum and articles of association, to the contrary, have any obligation to make further contributions to the Company's assets (except in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:84.96pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:21.43pt">The search of records of proceedings available at the High Court Registry would not reveal any proceeding which has been placed under seal or anonymised (whether by order of the Court or pursuant to the practice of the High Court Registry).</font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm under the heading &#34;Validity of Securities&#34; in the prospectus included in the Registration Statement.  In providing our consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the SEC Act or the rules and regulations of the Commission thereunder.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">This opinion is addressed to you and may be relied upon by you, your counsel and purchasers of Shares pursuant to the Registration Statement.  This opinion is limited to the matters detailed herein and is not to be read as an opinion with respect to any other matter.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Yours faithfully</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#47;s&#47; Maples and Calder</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Maples and Calder</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bhvn-20250815.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6555d043-5c7b-4b44-85af-cf97cb86b07f,g:a0978f3d-71d8-409e-8ad4-8e40337b1b3f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhvn="http://www.biohavenpharma.com/20250815" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.biohavenpharma.com/20250815">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20250815_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20250815_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20250815_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.biohavenpharma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>bhvn-20250815_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6555d043-5c7b-4b44-85af-cf97cb86b07f,g:a0978f3d-71d8-409e-8ad4-8e40337b1b3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.biohavenpharma.com/role/Cover" xlink:type="simple" xlink:href="bhvn-20250815.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.biohavenpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_583b0d84-c616-4983-b406-3ed84656b9c5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_eb32d264-5c36-41a4-9ab7-6554f7a1cb39" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_583b0d84-c616-4983-b406-3ed84656b9c5" xlink:to="loc_dei_DocumentInformationTable_eb32d264-5c36-41a4-9ab7-6554f7a1cb39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_91d91dee-add3-4f24-805b-f4c37ef61952" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_583b0d84-c616-4983-b406-3ed84656b9c5" xlink:to="loc_dei_DocumentPeriodEndDate_91d91dee-add3-4f24-805b-f4c37ef61952" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bhvn-20250815_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6555d043-5c7b-4b44-85af-cf97cb86b07f,g:a0978f3d-71d8-409e-8ad4-8e40337b1b3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_164b041b-fcd7-4afb-9fb0-e381c38cf5f2_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5b2f0e76-b712-4ec9-8f76-917a4422c88b_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_87551408-6674-43e6-8a05-d47fe46a33c2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_b09ec1f9-7fb9-4d9b-9dac-d8d59e5a23fc_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_64579441-3b1a-497e-b369-04aa7fef1e46_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f00fc20e-f8b3-4998-ae4f-713a5625a5d4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_dc1fa278-6041-404f-9464-3de87580c59d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_35a477d7-4275-44fe-b140-857f70b426c4_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8ab9c7ba-4698-4a4e-bd99-72759784e394_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_52c426e9-a359-4d3b-93f2-b1d85ca682d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_7639048f-e07c-4966-be7c-c4350938b750_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5fcc4084-5346-4a8a-b38a-09c8bf562a54_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_39b7ea1c-165e-4f59-aca3-352d0adc3976_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4e2ff854-d9d7-462f-8a3f-eba066c9f00a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_dc803f1d-a7ad-439e-b630-48de2af16dee_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7553cd36-03a6-423f-a850-58bbba92b732_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_5565719c-812f-44ff-a67b-504d1e372dd6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9799b14f-6cba-4203-b043-c05727dbb353_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6eb3b360-bc15-4627-9e58-ee3d7b8b9fe0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cd863afd-c5b8-452a-b839-1606c54d3a97_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f901521a-eaed-4b6b-89f6-c3312a6f2bae_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9820cc56-5c8b-4af3-a561-6cba643e7aa3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8923d2d5-00b4-4311-ab5c-783f3f6c6e92_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0a588867-54af-48fa-90f3-19be1f156fe0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bhvn-20250815_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6555d043-5c7b-4b44-85af-cf97cb86b07f,g:a0978f3d-71d8-409e-8ad4-8e40337b1b3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.biohavenpharma.com/role/Cover" xlink:type="simple" xlink:href="bhvn-20250815.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.biohavenpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4a45f1e3-9288-4b49-99e4-a16110afab3f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_DocumentType_4a45f1e3-9288-4b49-99e4-a16110afab3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_981c9bb9-2a60-4b25-b075-23dda29e1e4e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityRegistrantName_981c9bb9-2a60-4b25-b075-23dda29e1e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1d7d0644-9bf9-4d79-8f5c-753a295cdf67" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_DocumentPeriodEndDate_1d7d0644-9bf9-4d79-8f5c-753a295cdf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a79f545d-9c4b-4112-acea-437966f22409" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a79f545d-9c4b-4112-acea-437966f22409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_24e7e0fa-4d32-45f3-8a39-ff5734cb1cb9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityFileNumber_24e7e0fa-4d32-45f3-8a39-ff5734cb1cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_845e90c1-c255-428d-84b9-b1b0b67987a4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityAddressAddressLine1_845e90c1-c255-428d-84b9-b1b0b67987a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_473b8410-37ae-4c2e-bcab-f1500998cb1f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityAddressAddressLine2_473b8410-37ae-4c2e-bcab-f1500998cb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3cac177a-04ec-41ec-9685-eb3b6af377ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityAddressCityOrTown_3cac177a-04ec-41ec-9685-eb3b6af377ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7f98d88c-5d28-4d0e-bffc-84b7b412bb1e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityAddressStateOrProvince_7f98d88c-5d28-4d0e-bffc-84b7b412bb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b1f970b6-755c-433a-afa2-3e5de69c3ff0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityAddressPostalZipCode_b1f970b6-755c-433a-afa2-3e5de69c3ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f23d2a33-2eae-45e2-a39c-5a8593b19489" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_CityAreaCode_f23d2a33-2eae-45e2-a39c-5a8593b19489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e94a097a-976e-484f-b19f-039e5c83928e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_LocalPhoneNumber_e94a097a-976e-484f-b19f-039e5c83928e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_68b8b95d-d328-41b5-9c0b-08a16d8e5b95" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_WrittenCommunications_68b8b95d-d328-41b5-9c0b-08a16d8e5b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_1687f102-eab9-4b13-a0cd-aa115cc36ba5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_SolicitingMaterial_1687f102-eab9-4b13-a0cd-aa115cc36ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d0af50bb-b306-431c-a62c-7df652f139e6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_PreCommencementTenderOffer_d0af50bb-b306-431c-a62c-7df652f139e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_8ced296f-88fe-45e8-86ad-6c306b560834" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_8ced296f-88fe-45e8-86ad-6c306b560834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_25700ddd-40c9-4add-a08a-5f125bcdfd80" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_Security12bTitle_25700ddd-40c9-4add-a08a-5f125bcdfd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d42f5dc1-f8ec-47aa-beab-923edbf8dac0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_TradingSymbol_d42f5dc1-f8ec-47aa-beab-923edbf8dac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7bbb5fc6-0b4c-47be-b98c-4c68ce5ddee9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_SecurityExchangeName_7bbb5fc6-0b4c-47be-b98c-4c68ce5ddee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8dfe5fb8-011c-44b9-89e6-bafe7695e38a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityEmergingGrowthCompany_8dfe5fb8-011c-44b9-89e6-bafe7695e38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7aa3f267-dafd-44d3-a372-7b023786f8a1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_EntityCentralIndexKey_7aa3f267-dafd-44d3-a372-7b023786f8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a10e3dde-4656-4f0e-bc0b-d8d754d767d3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_AmendmentFlag_a10e3dde-4656-4f0e-bc0b-d8d754d767d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_eb32d264-5c36-41a4-9ab7-6554f7a1cb39" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_207ff4c5-5913-4746-99c9-fc354b05d9a1" xlink:to="loc_dei_DocumentInformationTable_eb32d264-5c36-41a4-9ab7-6554f7a1cb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_583b0d84-c616-4983-b406-3ed84656b9c5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_eb32d264-5c36-41a4-9ab7-6554f7a1cb39" xlink:to="loc_dei_DocumentInformationLineItems_583b0d84-c616-4983-b406-3ed84656b9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_91d91dee-add3-4f24-805b-f4c37ef61952" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_583b0d84-c616-4983-b406-3ed84656b9c5" xlink:to="loc_dei_DocumentPeriodEndDate_91d91dee-add3-4f24-805b-f4c37ef61952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M("
M     !%C<')T   !4    #-D97-C   !A    &QW='!T   !\    !1B:W!T
M   "!    !1R6%E:   "&    !1G6%E:   "+    !1B6%E:   "0    !1D
M;6YD   "5    '!D;61D   "Q    (AV=65D   #3    (9V:65W   #U
M "1L=6UI   #^    !1M96%S   $#    "1T96-H   $,     QR5%)#   $
M/   " QG5%)#   $/   " QB5%)#   $/   " QT97AT     $-O<'ER:6=H
M=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P
M   2<U)'0B!)14,V,3DV-BTR+C$              !)S4D="($E%0S8Q.38V
M+3(N,0
M            6%E:(        /-1  $    !%LQ865H@
M     %A96B        !OH@  ./4   .06%E:(        &*9  "WA0  &-I8
M65H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W
M+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC:
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M<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X (P H "T
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M.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^)
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MS'R5_@98\_P9^-IY9I-JQYTB):QZT
M
M
M
M
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MQ/Q;TM69IDQV[:9,=K8[QQK:8>LG<\N
M
M
M
M
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MUEGZ-ZNQ1&YI'?PYJ:SAW."TS%,^&T]M;=V8FLZ6QWK:EXBU995E6MD
M
M
M
M
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MW$C6MU=]CH_X_8/O?KWHKK'>F-=/+]#M2FWW^QW?^S9L=_M;1,_0UU<,<E6
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MU+UF:WI:MZS-;1,^A'8@0
M
M
M
M
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MS?;7M&.]IB9]1>)M:*;>%T,]LU"@
M
M
M
M
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MYM;+RW>WQ5O.D3DPSI?;Y9B.$>NP7QY=/)W]&194O
M
M
M
M
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MFT_?XCO0U>7=;<D\0-K33%S/8WVN:8[)S;2T6I:W[Z^'/%(_>X/0M!GJFML
M
M
M
M
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M<?-_ :.<=W[MRGG&US][3C%,OK-I:LSY*VMGQS.FNMJU]U?@+@-'H
M
M
M
M
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M$1/!LE2Y;\]8
M
M
M
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M(U[EXM7732=-8X.JG:EP      'WR)Z4;*W3H]BN?8ZM<Q_KN1$6%Z/9&_\
M[,UO;T5/FR*_HJHJ&D_VVO&''XB>)4=)<FR1?IGIV<F"+5F>[EWEIB-UD[=)
MKCFE=O2=.$X\MZVFN6'[9?\ !$]CO/[/'LU6\7NLMM.'Q,\1J[??32]8[^TY
M-BK>>58.R;4R;JN;+S#/$6CO4W&TQ9<=<NUE^)A<W5/]8YS'->Q>US'(YJI]
MAS5147X_:5#[$Z3K':X9,=,N.V+)$6QVB8F)[)B8TF)]$PX*]"V"U+''V>FO
M;)&C)%E1D<S&S1Q.D5K.Z6%LB,?\$^>U3T6')ZW%6_EF/I^5B5S[EEN3\XW'
M+;:]W%DF*Z^6D\:3[]9B4DOLYXB3-^YGXB4XY?2=#R-?RZO]-TO6/7],VC/2
MQ=K7-5/6BQJL[OD9W=RHJ)T)CDL=[FF&/WW[$3+%_P!K/=5V?LZ=59K1K$\O
MK3MTXY=QAQ1/O3?73RZ:>5LIBYK\\8
M
M
M
M
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M>:<8GR;29X:3P[=-8G8(%PVB<
M
M
M
M
M   #K^VZY1W'5=FU'*)UQFTZ_F=<R*=J/ZT<YCK.,MIV*J(_K7M.^"JB*5W+
M-_FY5S+;\TV_^T;;/CRU^VQVB]?IQ"+YWRK;<^Y+N^1[S_9-[M<N"_E^!FQV
MQVX>7X-I5!-BP61U;8,[K.7A6OEM<S.3P64KKUZP9'$79\?=A7JB+UBLUW-^
M/VC:+L-[@YCL</,-K/>VV?%3)2?/6]8M6??B8:+^:\MW7)N:;GE&^KW=[M=Q
MDPY*^:^*\TO'O6K,.&*M0  #IN[:;0W/$OI6$CAOP(Z3%Y%S%5].PO;W(Y6?
M/?5L(U&RL^**G1R)WM:J2W)^;9N4[J,U-9P3PO7[*/JQVQ/O=DSK ]0<AVW/
MME.WR:5W->..^G&L^]QFMNRT>Y.FL1,80Y;%7,3>NXC*U5@MU)'U[5:5&O;\
M4^5%3NCF@FC<CF.:JLD8Y'(JM5%+P;?<8=W@KN=O:+8;QK$_Y=DQV3$\8G6)
MXK ;G;;OEF\MM\\6Q[O%?CY)B8XQ,3'O36T3I,:3$Z3$H_.9N+Y=,R;LSB8.
MNL92=RQ)&B],3<D57NHR-1/F5G_+ [Y.B*Q>BHG=,[7/WX]7?X\=GI_=C]CC
MQXLK_#OK:G57+OFV\M6.>[>L>LCL]97LC+6.SCPB\1PK?R5K>D/#BL7&   #
MZ8(6/ZRS.5L#%1%1JHDLS_E2&'JCD153^$]45L:?%455:UUAO'KQ]Z5\#>FK
M;[F-J;GJK<4GYGL8M$9,UN,1DR1'PL>VI:)]9EF..DTQ][),59Y>P9[ OBO[
M<_B9BY!TUBS\M\+=AGK/.>>WQ6G;;+%'=M;!@M,13<\RS4M'S?:5MK\*,V><
M>VK?)'].<KW=51$^#6HB?(UK&HQK4ZJJJC6M1/BJK]LT/=9=8]0]?]2[OJ[J
MK<6W//-[D[^2\\(CA$5I2L<*8\=8BE*5X5K$1#]YO@QX-^'?L_\ AGRGPB\*
MN7X^6=#<EVWJMOAK,VM,S:;Y<V;);X6;<9\MKYL^:\S;)EO:T]ND?R>870
M'\V6V9<;<CB[5KP/JY"UU[4<B0R.H0N:Y?G+TDRG16I\O7JOR%?R^9C--?)-
M?VX6O\5MOBOR/!N;?+8]S%:^Y>EN]'O]V)U]'I6W?JO'!<];!^3GDID:O2#*
MY'5N$]1M*U[7+]YH%W??F*KF(R2&5^7UWL5CO@^&1'?8+E=*[?2N7=3Y9BL>
M]QG]FK1'_B2]:TR;WISP\V]OAXL>;F&>O^LGYOMO<F.YNM=?):NGE6U#U[5N
M
M
M
M
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MFWCU6"8K/&LY*5]=>OWS)?SLXBO68
M
M
M
M
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M/)/R77G/=L*VSPSXZ7,1L#WWJSI*>S\M0W*F9T37JJR-2"=FNV*+<SD.BO\
M3;!5@DC5EU')Z_H_EEMWO_GEX_FV'Z=Y[(CW.V?>CRM9W^)OX_[/PS\'Z^&?
M)\\QUSU3WJ16EM+8.75UKNL]].,>NF8VV&)B.]-LV2MN]MYB;Y!=E^;P
M
M
M
M
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M,3V4Q4[9TB<F2<F:^N3)>9R7*Y:,
M
M
M
M
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MVYR1PG36N*GW*DV^'DR9D%[&.
M
M
M
M
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M$$O5:]&#M@B3YSO4F629^S_PQ\)ND_"OE/S#D&*;\PRQ'K]UDB)S9ICSS$?
MQQ/Q,5=*U[9[UYM>VEGQG\=^N_'#GO\ 6G5.:,?*L-I^:[+%-HVVVK/EBLSK
MDS6CY3/?6]^R.YCBF.N2)<Y9<
M
M
M
M
M             \9Y:\?^*>:Z2U]]U:I=R$<*P4MDH=,;LV-;\Y6)5S%=J3R0
MQ.<KD@G2:LKEZNC4M3XE^"GAOXM;3U/67+L>7?5IW<>ZQ_<MWBCR=S/6.]-8
MF=8QY/68M>,XY7)\/_%OK[PRW/KNE-_DQ;.;=Z^VR?=-MDGR][#;X,6F.$WI
MW,FG"+PC$Y/]M'=<3)8O\3[9CMLQZ+(^+!;,YF"V&./N^Y5X<E$Q^"R<W;_"
MDE^]S?M--?7B%[ G5G+;Y-YX;<RP<SV6LS7;[O3;[F(\E:Y8B=OEMY[7^:QY
MJLX.AO;7Z9YA2FUZ_P"7YN7[O2(G/MM<^WF?+:<<S&?%'FK7YQ/GLP8W7@[E
M_CI\K=SXYVW!P0]W?D9<19MX5>SKW^EG<>VWAI^Q$ZKV3NZ-5%^145</NK/"
M#Q0Z&O:O57(>9[3%777+.&]\$Z=O=W&.+X+:>7NY)X:3V3#*7IGQ1\.^L:UG
MIKG/+]UEMIICC+6F;CV:X,G<S5U\G>I''6.V)1XGKV8(  YK ZWL6TWX\5K&
M!S6QY.542+&X'%WLO?E5R]&I'3Q\%BP]57Y.C5*[E_+.9<VW$;3E6WS[G=V[
M*8L=\EY]RM(F9^@C.:\ZY/R+:3O^>;O;;/8U[<F?+3#CCW;Y+5K'ORS7XL]M
M[RIY,FJRW-'9QOA)U8Z7,<CVTP,T,:N1)&IK<3+NU_2&Q]5:V2E%&Y>B*]O7
MJE\^DO9D\6^J;TOFV$<LV-M-<F]MZJ8CR_<(BVXUT[(G%6)[)M#&;KOVSO ;
MHG'?'M^:3SKF===,/+J>OB9TX?SF9IM>[KPF:YK6B.,5GL2Q\#>UAPCQI+2S
MO)UNQS)L]=(YDI9:FW%:)3LM7O\ N>LQ6+4V:2/N5B_?&S/6F:B.6LQ5Z)E_
MX?>R7T)TO>G,.JKVYWS6ND]W)7U>TK;MX8(FTY=.S[M>]+1Q]56>$8!>*WMW
M^)_6V/+RKHC'3IOD=]8[^*_K=]>O9QW,UK&'7XT?-\=,E)X1GM'&9-Z%"CBZ
M57&XRE4QV.HP15:5"A7AJ4J=:%B,AKU:M=D<%>")B(C6,:C6HG1$,I]OM]OM
M,%-KM:4Q;;'6*UI2L5K6L<(K6L1$1$1PB(B(AA#NMWNM]N<F]WV7)FWF6\VO
MDO:;WO:TZS:UK3-K6F>,S,S,SVOK.Y3@
M
M
M
M
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MVW$[OFFXS[G=3VWRY+9+S_G7F9^FY,JE"
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M;UBU;5F)BU9C6)B8X3$QQB8X3#ESH=@
M
M
M
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MVF9M:9F9F9G69F9XS,SQF9XS+)2M:TK%*1$4B-(B.$1$=D1'F?4<'(
M
M
M
M
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MLO\ !EJBS=4P7;G<T#-B8   88>X_P#W>/GG_8P\HOZC]Y/?^$__ )2Z:_\
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MT<RYACO,?.YP8YKY^Y%K=_Z<XUXXUTLEP
M
M
M
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MO9B 2(
M
M
M
M                 #3_ /E)^TWY%_IVY=_K V$WJ=&_H?RK\V[7\11@!SO^
MVMY^59?QEFS]]J/^[5\&O[,G$GY)X\T]>-7_ );ZC_/&Y_&V9J="_H;RS\BQ
M?P85^OK,7MB_C-@_^(CPOK_?L&L4L7K_ )-83%P]TV7U>LVOB=4Y:;6B9WRW
M=79Z.*S+T[U7&_0["M9'2M2NR>]D7Q@^9[G]5G4&7^:YK6OR^]IX5R3K;)MM
M?)&3CDQ1P^Z>LKK,Y*1%J?&7HOU^+_NWEU/NM(BNYB/+6.%<ONUX5O\ O>[/
M"*VE"9[%_N63> ?E)3UOD78):7C)SS;Q>I<LQVYG.Q>D9M))*^G\M10KU2LW
M6;EM:^7?'T63"V9Y',FEJU6-R$]H[PCKXF]&VW?*L46ZOY96V7;:1\+-3MR[
M;7R^LB.]BB>S+6L:UK>\S;?PRZRGI7G<8=W?3DNZF*Y=>RD_69?\V9TO^\F9
MTF:U7M_<J\]=(]OOQ*W3R!RDF*SVV7*\6L<*ZC-;8Z+?>2MAJ3OUNHB0V8);
M.NXJO%)ELK)#(UZ8JG-Z3EF?"U^MWPD\-.8^)_6^WZ7PQ?%LJSZS=Y8CY';T
MF/63QB8B]ITQXXF-/67KWH[L6F,GNL>J=MTIR')S:_=OGF.[AIK\?):/@Q]K
M'QK:?6Q.G'1K$-1U;G7S?\EL;K6)=E^3^?O(ODJ=\MV_+)+=SVW;;DI\EFL_
MFK;(I&X_$T&R3WKUCL2O0H022JC8HEZ;@M]O.F_#OI&^[S^KV?3/*MI&D5X1
M3%BK%:4I&OPK6X4I77O7O,1QM9A;M\',^I><UPX^]GYKO,W;/;:]YUFTSY(C
MC:T]E:Q,]D-I=X%^&O'G@7XO\;^.7'K(+7XLX],IO6UMK?1[?(')>9@K2[IN
MU]KE?.W[ZY"%(J4,CY74<77JU$>YE=BFFKQ+Z^YIXE=8[OJOFDS7UUN[AQZZ
MQ@V])GU6&OD^#6=;S$1W\EKY-(FTLW.ENG=ITMR3#RC::3W(UO;RY,DZ=^\^
M[/"(X]VL5KKP4[?K8?[9GCE_9CK_ -:G(9GA[$_Z \V_/$_\-@8^^.OZ1;/\
MB_\ NY'M'U2#\XGF]_,O@S\.<FGG_;@_LKIW\HWG\#;I'P%_VOF7^KP_PLB[
M>:\V20!1<^M5>7'XX\U\->&>MY+U,+PY@OZ6>2JU:SW0R\B;_2=3T[%Y*LV9
MR1Y#5M 8^["YS&N]#9EZ*J+\-CGL7]#_ ##I[?\ 7V[IIN-_D^;;>9CCZC#.
MN6U9T^+DS:4GC\;;L9/''G_SCF6WZ=PV^Y[>OK<D:_\ J7C2D3'GK3C'HR.L
M?58/$I.0?)+E7RZV3%LGU_@#55T?0+-B)BHO*/)U2U4RN2Q\B]Z^MK?',%^K
M83HU438(515Z.0K/;-ZW_JOI+9=#;2\QNN9YO79HC_=]O,36MO1DSS2U?]39
MT^"'(?G?.,_/\U=<6TIW*3_]7)$Q,Q]KC[T3_K(7RC6NRA8E^=GC'A_,CQ$Y
M[\;LLVNV?DS0,I1U>]:[?0P^_P"'=#L?'>=F5S7+]'PN\8C'V9FM5KI((WL1
MS>[JGM_#?K#/T%USRSJS!KW=GNJSDB.V^&VM,](]-\-KUCS3,3I.B!ZGY+CZ
MAY!NN3Y--<V*8K,^2\?"QV]Z\5F?1P:GO!9G?>#^4L-L.+=DM+Y0X@W_ !^9
MQSYX5KY?4]]X_P!BAO5'35YF]8,E@=AQ+5<QR?-EBZ*GP-U^YV_+.HN39-KF
M[FXY/O\ :VI;2=:Y<.:DQ.DQVUO2W;'DE@KBR;KEF^KFIWL>]V^6)CSUOCMK
M'OUM'T8;;;Q2\@M8\K/&_A;R*U#T8\)R[Q]@-O\ H$%A+28/,VZJ0;/K$]AO
MPDNZILU:YC;"_8GJO0T@]:]+[SHKJSF'2N_UG<;'=7Q:S&G?I$ZX\D1YLF.:
MY*^BT,\N1<VP\]Y/MN;[?3U>XQ5OIV]V9CX5?=K;6L^F&01Y=+/%_)#]GCGK
M]"_*/Y#YTG^D_P!*>6_G#;_CJ([G']D;K\FR_P "S3X&]IK]7U_''ZR?[>/%
M7CSP/Q?L^$\C9-EXWX9XOT'89,7QKJUO&/SFGZ1@]>RS\=:FY'JS6:#K^.D6
M&1\4;GQ]%5K57HFM/JOV2_%+G75/,N<;/)RF-IN^8;C-3O;C)%NYES7O7O1&
M"8B>[:-8UG2?++*3E'C%TEL>4[799J[SUV';XZ6TQUF.]2E:SI/K(X:QP>EY
M_P"M/^W3BZ#Y\1Q_Y5;+>5LK:]"EQWQUCF^LD,CX'7+F7Y=I1UZDDS6L>^)M
MB5G=W)$[HJ$1MO8R\5<V3NY]UR7#CX:VG/GMPUXZ17;3K.G&(GNQ/GA69?&_
MI&E=<>+?7MYHQXX^C,Y8X>YK/H0M^>WUFGG_ ,AM2V'BKQ7T&7QDTO8*]S$Y
MGD2SLK=DYFR^%MQMBFAP5^AC\7A.-);E=\D4TE-<ED8T5KZM^N].ID!X:>R'
MTQTMOL7.NL]S'..88IBU,$8_5[6MXXQ-ZVM:^XB)TF(OZND]E\=X6YZI\9N:
M\VV]]CR/%\RVUXF)R3;O9IB?L9B(C'KV3IWK>6MHE SXE^(W.?FQS1K7!G 6
MH6MGVS/3QRY/)RLL5]6TC7631QY/<MYSD5>Q#K^L8ADB+),]KY9Y7,KUHY[4
MT,$F2O6_7'3GA[T_FZCZFSQAV.*-*UC2<F:^GP<6&FL3?);R1&D1&M[S6E;6
MBUW(>0<SZDYC3EG*L<WSVGC/UM*^6][?6UCS]LSI$1-IB)VF'A%XC<?>#7C+
MQAXU<<R/R&+T/$2.SNSV:L5/);MNF8L293;]QR<$<DZP39S-V97P0++-]"I-
M@JMD=' Q333XA]<<T\1NK]YU;S:(KFW-_@8XG6N+%2.[BQ5GAK%*1$3;2._?
MO7F(FTLW>FN0;3IGDN#DVSXTQ5^%:8TF]YXWO/VTZZ1K.D:5UTB'E?NN?W:O
MG+_9DY;_ "3R!->"O_EOIS\\;;\;50]=?H;S/\BR_P &6J+-U3!=N=S0,V)@
M  !AA[C_ /=X^>?]C#RB_J/WD]_X3_\ E+IK_P"0<N_XO"\[UA^B7-/S=N?Q
M-VI7-W3 YW"/CW?IHXYH='W"6*5C)(I8]:S3XY(WM1S)(WMI*U['M5%14545
M%*">:<LK,UMN<$6B>,>LI]541M-W,:QBR:?:S]1_?]'/(7\@]S_T7SG^(GS^
MMN5?[SM_PE/JOOS/=_>LG^C;ZA_1SR%_(/<_]%\Y_B(_K;E7^\[?\)3ZI\SW
M?WK)_HV^HV0/U=;%Y/#^U1PA0R^.O8J]%N7-;I:62J6*-N-LO+&UR1N?6M1Q
M3,;)&Y'-54^*+U0U/^U3FP[CQIYCEP7K?'.WVG&LQ,?[-C\L<&7_ (1TOCZ&
MVU,D36WK,W"8TGY6WG3AF.RY;^7-:]KF/:U['M5KV.1'-<UR='-<U>J.:Y%Z
M*B_*?8F8G6.T5<O<+^K-\+^0.Q;!RQX=[AA_''D+.V+N5S'&6=QEZ_P?GLS;
M=)/)/AEPS;&P<6-MW)5?-'1J97&QMZ,JX^NU/CF/X6^UWU!TQM<7).O,&3FW
M*\<16NXI:*[NE(X:7[^E-QI'")O;'DGMOENLEU9X,\NYMFOO^GLE=GN[3,SC
MM$SAM,^;3X6+6>WNQ:OV-(53?)CV=O<7\4I,K;Y&\:-WV'4,5ZLTG(O$]7^E
M72'8Z)R,7+W<AIB9/)ZQCW/7M1<U3QDJ+TZQIW-ZYI=(>/'A5UK%*<JYOM\6
M^OP]1N9^;9N]]C%<O=KDM_JK9(]/"5C><^'W5W(IM;>;++?;U_\ 4Q1ZVFGG
MF::S6/MXK/H1]Z+R!R!Q5M-#<^-=UV_CG=,+*YV,VG2MAS&I[+BY4<G?]#S.
M$MT,E4<KF)W(V1O7IT4NAS+E?+.=;.VPYOM\&[Y?DCX6/+2N3';W:7BU9]^'
MD]KN]WL<\;C9Y,F'<U[+4M-;1[DUF)A9V]N+ZR]SAQ7G\#QIYY2V.;>);4M3
M&,YBQN)I5N7]!KI&VM#?SE7$5J6/Y/P=;TV+9]6&+/JCI9_I5Z1&57X?>*_L
MC=.\ZVN7F_AK$<NYY6)M\UM:9VN:>V:TFTS;;WGCW=)G#V5[F.-;Q>GI#QEY
MGL<M-GU1KN=A.D>MB(C+3TVB(B,E?/K$7[9[UI^#-ZO3MPU?D'4]:WO2,]C-
MITW<L%BMGU;9<+:CO8C/:_G*4.1Q.7QMR%71V:5^C89+&]/E:Y#7#O\ 8;SE
M>]S<MYCBOAW^WR6QY,=XTM2])FMJVB>R:S$Q,,G-ON,&[P4W6VM6^WR5BU;1
M.L6K:-8F)\TQQ=D*1W
M
M
M
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MUG[36>,S+(+P/YQFWO(=SRG-:;?,\U9IKY*98M,5CT1>EYC[;3R+1YANO:
M
M
M
M
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M>BJBY%^-W0_ZP?#/F?(,-._S.N+U^V\_SC!]TI6OFG+$6PZ^2N25L^@^??\
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M?^SQP+^A?B[\A\$:)>K/TIYE^<-Q^.NV!<G_ +(VOY-B_@5>T$ D0
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MUR6GZ62%P8P39 @
M
M
M
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M6W;\)_V,_$C^S'P)_57JAHU\0OT^YY^>-Y_Q.1GSTW^CNP_(L'XJK)P\@F@
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MV'!BO$6KEW-J1W[6I.L6IAQWC2+1I;)DK,3KBM"R7C'UCEY3LL?3O+KVIO\
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M.ZXWRS'9.6_&VGGBL:4B?+6L2D0+6/6@
M
M
M
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MQUXQ2)\LZVO,3,3;2=$Q98=<(
M
M
M
M
M
M
M
M
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M>&V2-8F'1FW-<-HK:)G6'AG_ !*>*?Y"<@_\S7/X\.SYK?SPZ?GV/S6^D?\
M$IXI_D)R#_S-<_CP?-;^>#Y]C\UOI.6Q7N/\*W)DAR>M<B8=KGM1++L7@;U9
MC5Z(KYOHNQ+;;V]?D9#(JHGV_@?)VV3SP^QOL4]L6C_+W647''/_ !!RPYD&
MC[QB<GDWL=)]XK+IL3GT2-JNF5N&RL5._89 C5[I(621(GQ[NBHJ]5L=Z?&C
M@J*9L63XDQK]-[&<':
M
M
M
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M
M
M
M
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M\
M
M
M
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M6JYB.5TLJ(B=4Z_;)&9TC5"Q&LQ$=LK4Y$O0@
M
M
M
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M:]V/C3^PY[/#-\G?GXM?V4Y!0)8
M
M
M
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M2]#6.[6(\T(EO<O_ ,^>,_YIY;\,-*S:_%GW4;O_ (]?<<3[:WYUM[_1Z_\
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M9FTZSVI&M:UCNUC2(<X?'T
M
M
M
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M^V>VM^=;>_T>O_*/!C=?$CW38?*3]K^VF>*)*
M
M
M
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MQB41$VI;6.%H3$\'^?VA;70I8;EIS-&VJ*.*"3-M@L3ZGFID1&_26RUXY[&
MGE7JKX[#5K,^5)_CV-HLFWM'&G&$GBWE+1IDX6^E^XSJP.XZCM,$=G6-IUW8
MJ\R=T4V#S6-RT4B(U7*K'T+,[7=&HJK]I$*>:S';$PJZWK;XLQ+\M@W?3-4A
MDL;1MNM:[#$CEDDSF=QF*:WM1CE15NVH/G=)&_#Y5[D^V@BMK=D3):]*_&F(
M8$\Z^X#IVNT+V!X:Z;=L\K)*S=ILU9H=6PKUZL?9J16F0VM@N0]%]-$8RGW*
MUZR3,18GU&/;VF=;\(4>;>UK&F+C;S^3]U$2YVU<A;4YSERVU[?M645RKTFR
M&6S&5O2]57HG?+-+*]W_ *&M3[#4^%;PK'FK"-^%>WGM*>_Q1\>X.!="=!E4
MK6=\VAT&1VV] L<L=18V.2AKM*PQ/NM+$,E>KGHKDELR2O158L:-CLV3UEN'
MQ8[$QML'J:<?CSV_492G4J'E/-O%U#F/C+:- NR1UILM327$9"5KG-QF>HR-
MMX>^Y&(LJP178FMF:SYTE=\C$_A'/'?N7BSKRXXRXYI/E5O-FUO/:5L66UC8
MJ%C$9_ 7Y:.0I3(K):]J!R*CV/3X212L5LD4K%5DD;FO:JM<BK)Q,6C6.Q!V
MK-+=VW"T)6?&GSOP5G$X[2><,A)B\S1CAI8W?I8I;&.S%=B-BKQ[*M=DD^/R
MD:=K77%8ZO.WJ^9T3T5TE'EV\Z]['V>9(8-Y&G<R\)\_U4D&%VS5MDIID-=V
M7 9Z@Z%;"7</F,?DZJP-:QSIO7I6)HDB:V1JJ[KT1')U^4IIB8G28XJZ+5M&
MM9B8>5<F>2?#7%-&Q/LNZXFUDHF2>CK6 M5LWL=J9C>K8$QM*9ZT?57X-EMN
MKP=>O5Z=#G3%>_9'!UY,^+''PIC7S>5"!Y%>0NR^0.VQ9;(PKA]9PK9ZNJZS
M'.Z>/'5IWL=8NW)NC&6LQD/29ZTJ-:U&QL8U.C.KJ[%CC'&D=J)SYK9K:SPK
M'9#);P X(O;+N3>8\_1DBU?3WV(=86S$J1YS:98I*S[55'I]UIZ[#(Y[I$3I
M],=$C%5T4J-Z]QDTKW([95&SPS:WK;?%CL]W]Q,\4*40P^Y3^=;1/T>L_*/.
M%;M?B3[J+W_RD?:_MGMK?G6WO]'K_P H\&-U\2/=-A\I/VO[:9XHDH
M
M
M
M
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MCY.QJKVHJKT15&YF)K&GG-C6T9)UB8X?MIA"B28
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
:                               ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Biohaven Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 15,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">D8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">c/o Biohaven Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">215 Church Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Haven<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">404-0410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHVN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001935979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 15,  2025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bhvn-20250815.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biohavenpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="bhvn-20250815.htm">bhvn-20250815.htm</File>
    <File>bhvn-20250815.xsd</File>
    <File>bhvn-20250815_def.xml</File>
    <File>bhvn-20250815_lab.xml</File>
    <File>bhvn-20250815_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bhvn-20250815.htm": {
   "nsprefix": "bhvn",
   "nsuri": "http://www.biohavenpharma.com/20250815",
   "dts": {
    "inline": {
     "local": [
      "bhvn-20250815.htm"
     ]
    },
    "schema": {
     "local": [
      "bhvn-20250815.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bhvn-20250815_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bhvn-20250815_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhvn-20250815_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.biohavenpharma.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bhvn-20250815.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bhvn-20250815.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.biohavenpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001935979-25-000074-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001935979-25-000074-xbrl.zip
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MXJSO@5]>6>^7E_4W\]6']CO_!U!+ P04    " #5B@];68ZI4W "   )"
M$0   &)H=FXM,C R-3 X,34N>'-DW57+;MLP$+S[*UB=2STL*Y:-V &:($ !
M]P$W07,K*&IE$9%(E:1LY^]+TA(<Y=6ZIZ(Z4;LSNSNK 75^L:\KM 6IF. +
M+_)##P&G(F=\L_!N;ZYQZETL1Z/S=QC??5BOT)6@;0U<HTL)1$..=DR72)>
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M,+QA#N^/;B$7.%QMR]$O4$L#!!0    ( -6*#UNCSCY+\0(  "X+   5
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M,=+) OY)BZEZ]7]02P$"% ,4    " #5B@];L;#/*_$0  !W8@  $0
M        @ $     8FAV;BTR,#(U,#@Q-2YH=&U02P$"% ,4    " #5B@];
M68ZI4W "   )"   $0              @ $@$0  8FAV;BTR,#(U,#@Q-2YX
M<V102P$"% ,4    " #5B@];H\X^2_$"   N"P  %0              @ &_
M$P  8FAV;BTR,#(U,#@Q-5]D968N>&UL4$L! A0#%     @ U8H/6UK<[DV9
M"@  E5L  !4              ( !XQ8  &)H=FXM,C R-3 X,35?;&%B+GAM
M;%!+ 0(4 Q0    ( -6*#ULP:',30P<  #XW   5              "  :\A
M  !B:'9N+3(P,C4P.#$U7W!R92YX;6Q02P$"% ,4    " #5B@];YJQNF$\3
M  #D@@  '@              @ $E*0  97AH:6)I=#4Q;6%P;&5S;W!I;FEO
?;F%N9&,N:'1M4$L%!@     &  8 DP$  + \      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>bhvn-20250815_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bhvn-20250815.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001935979</identifier>
        </entity>
        <period>
            <startDate>2025-08-15</startDate>
            <endDate>2025-08-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001935979</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-08-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Biohaven Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">D8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-41477</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-6">c/o Biohaven Pharmaceuticals, Inc.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-7">215 Church Street</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">New Haven</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">06510</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">203</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">404-0410</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">BHVN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
